[Audio Only] BT02 Clinical Demonstration 01 – Integrating Ericksonian Methods – Jeffrey Zeig, PhD

You are currently accessing the institutional-grade blueprint for <b>[Audio Only] BT02 Clinical Demonstration 01 – Integrating Ericksonian Methods – Jeffrey Zeig, PhD</b>. Instant digital deployment and lifetime encrypted access are guaranteed immediately upon transaction clearance.

[Instant Download]

– Immediately deliver the download link after receiving the payment

Purchase [Audio Only] BT02 Clinical Demonstration 01 – Integrating Ericksonian Methods – Jeffrey Zeig, PhD courses at here with PRICE $15 $5

---

Topic Areas:

Clinical Demonstration

Category:

Brief Therapy Conference | Brief Therapy Conference 2002

Faculty:

Jeffrey Zeig, PhD

Duration:

47:12

Format:

Audio Only

Original Program Date :

Dec 13, 2002

Description

Description:

Educational Objectives:

1. To describe how to conceptualize challenging patients in a cognitive framework.
2. To describe how to use a cognitive conceptualization to plan more effective treatment.

*Sessions may be edited for content and to preserve confidentiality*

Faculty

Jeffrey Zeig, PhD Related seminars and products: 303

---

Jeffrey K. Zeig, PhD, is the Founder and Director of the Milton H. Erickson Foundation and is president of Zeig, Tucker & Theisen, Inc., publishers in the behavioral sciences. He has edited, co-edited, authored or coauthored more than 20 books on psychotherapy that appear in twelve foreign languages. Dr. Zeig is a psychologist and marriage and family therapist in private practice in Phoenix, Arizona. 

• Site at Jeffrey Zeig.com

---

Salepage: https://catalog.erickson-foundation.org/item/bt02-clinical-demonstration-01-integrating-ericksonian-methods-jeffrey-zeig-phd-65908

Archive: https://archive.ph/wip/xm2Vl

Purchase [Audio Only] BT02 Clinical Demonstration 01 – Integrating Ericksonian Methods – Jeffrey Zeig, PhD courses at here with PRICE $15 $5

Trading foreign exchange, cryptocurrencies, and algorithmic assets on margin carries a high level of risk and may not be suitable for all investors. Past performance of any trading system or quantitative blueprint does not guarantee future results.<br><br><b>Asset Classification:</b>